Related Experiment Video
Updated: Jun 18, 2026

08:21
Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
Reproducibility of a local cooling test to assess microvascular function in human skin
1Clinical Research Center, Inserm CIC03, Grenoble University Hospital, France. MRoustit@chu-grenoble.fr
Microvascular Research
|November 17, 2009
Summary
A 30-minute laser-Doppler flowmetry (LDF) cooling test demonstrated high reproducibility for assessing skin microvascular reactivity. This method is valuable for evaluating conditions like Raynaud
Area of Science:
- Physiology
- Biomedical Engineering
- Vascular Biology
Background:
- Assessing skin microvascular reactivity is crucial for understanding vascular health.
- Laser-Doppler flowmetry (LDF) is a key tool for measuring skin blood flow.
- Reproducibility of microvascular reactivity tests is essential for reliable clinical application.
Purpose of the Study:
- To evaluate the reproducibility of a custom-designed laser-Doppler flowmetry (LDF) probe for assessing skin microvascular reactivity during local cooling.
- To compare the reproducibility of short-term (5-min) versus longer-term (30-min) cooling protocols.
Main Methods:
- Twenty-two healthy volunteers participated in the study.
- Local forearm cooling at 15°C was applied for either 5 or 30 minutes.
- Skin blood flow was measured using LDF, with repeated measurements to assess reproducibility (CV, ICC).
Main Results:
- The 5-minute cooling protocol showed good immediate reproducibility (CV 8-18%, ICC 0.78-0.85).
- The 30-minute cooling protocol exhibited higher reproducibility at one week (CV 23-26%, ICC 0.75-0.86).
- Local cooling was well-tolerated by all participants.
Conclusions:
- A 30-minute LDF cooling test offers a reproducible method for assessing skin microvascular reactivity.
- This test has potential applications in evaluating microvascular function in diseases like Raynaud's syndrome.
- The developed tool can aid in the evaluation of therapeutic drugs targeting microvascular disorders.

